Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 150

1.

Effects of pretransplant plasmapheresis and rituximab on recurrence of focal segmental glomerulosclerosis in adult renal transplant recipients.

Park HS, Hong Y, Sun IO, Chung BH, Kim HW, Choi BS, Park CW, Jin DC, Kim YS, Yang CW.

Korean J Intern Med. 2014 Jul;29(4):482-8. doi: 10.3904/kjim.2014.29.4.482. Epub 2014 Jun 27.

2.

Preemptive plasmapheresis and recurrence of focal segmental glomerulosclerosis in pediatric renal transplantation.

Gonzalez E, Ettenger R, Rianthavorn P, Tsai E, Malekzadeh M.

Pediatr Transplant. 2011 Aug;15(5):495-501. doi: 10.1111/j.1399-3046.2011.01478.x. Epub 2011 Feb 21.

PMID:
21338460
3.

Rituximab and chronic plasmapheresis therapy of nephrotic syndrome in renal transplantation patients with recurrent focal segmental glomerulosclerosis.

Rodríguez-Ferrero M, Ampuero J, Anaya F.

Transplant Proc. 2009 Jul-Aug;41(6):2406-8. doi: 10.1016/j.transproceed.2009.06.044.

PMID:
19715934
4.

Rituximab therapy prevents focal and segmental glomerulosclerosis recurrence after a second renal transplantation.

Audard V, Kamar N, Sahali D, Cardeau-Desangles I, Homs S, Remy P, Aouizerate J, Matignon M, Rostaing L, Lang P, Grimbert P.

Transpl Int. 2012 May;25(5):e62-6. doi: 10.1111/j.1432-2277.2012.01462.x. Epub 2012 Mar 13.

5.

Success with plasmapheresis treatment for recurrent focal segmental glomerulosclerosis in pediatric renal transplant recipients.

Straatmann C, Kallash M, Killackey M, Iorember F, Aviles D, Bamgbola O, Carson T, Florman S, Vehaskari MV.

Pediatr Transplant. 2014 Feb;18(1):29-34. doi: 10.1111/petr.12185. Epub 2013 Nov 25.

PMID:
24266922
6.

Kidney transplantation for primary focal segmental glomerulosclerosis: outcomes and response to therapy for recurrence.

Hickson LJ, Gera M, Amer H, Iqbal CW, Moore TB, Milliner DS, Cosio FG, Larson TS, Stegall MD, Ishitani MB, Gloor JM, Griffin MD.

Transplantation. 2009 Apr 27;87(8):1232-9. doi: 10.1097/TP.0b013e31819f12be.

PMID:
19384172
7.

Plasmapheresis treatment of recurrent FSGS in adult renal transplant recipients.

Matalon A, Markowitz GS, Joseph RE, Cohen DJ, Saal SD, Kaplan B, D'Agati VD, Appel GB.

Clin Nephrol. 2001 Oct;56(4):271-8.

PMID:
11680656
8.

Use of rituximab in focal glomerulosclerosis relapses after renal transplantation.

Dello Strologo L, Guzzo I, Laurenzi C, Vivarelli M, Parodi A, Barbano G, Camilla R, Scozzola F, Amore A, Ginevri F, Murer L.

Transplantation. 2009 Aug 15;88(3):417-20. doi: 10.1097/TP.0b013e3181aed9d7.

PMID:
19667947
9.

Preemptive plasmapheresis and recurrence of FSGS in high-risk renal transplant recipients.

Gohh RY, Yango AF, Morrissey PE, Monaco AP, Gautam A, Sharma M, McCarthy ET, Savin VJ.

Am J Transplant. 2005 Dec;5(12):2907-12.

10.

Effect of pre-and postoperative plasmapheresis on posttransplant recurrence of focal segmental glomerulosclerosis in children.

Ohta T, Kawaguchi H, Hattori M, Komatsu Y, Akioka Y, Nagata M, Shiraga H, Ito K, Takahashi K, Ishikawa N, Tanabe K, Yamaguchi Y, Ota K.

Transplantation. 2001 Mar 15;71(5):628-33.

PMID:
11292291
11.

Long-term outcome of focal segmental glomerulosclerosis after pediatric renal transplantation.

Fuentes GM, Meseguer CG, Carrion AP, Hijosa MM, Garcia-Pose A, Melgar AA, Torres MN.

Pediatr Nephrol. 2010 Mar;25(3):529-34. doi: 10.1007/s00467-009-1361-0. Epub 2009 Dec 3.

PMID:
19956977
12.

Successful treatment of recurrent focal segmental glomerulosclerosis with a low dose rituximab in a kidney transplant recipient.

Cho JH, Lee JH, Park GY, Lim JH, Kim JS, Kang YJ, Kwon O, Choi JY, Park SH, Kim YL, Kim HK, Huh S, Kim CD.

Ren Fail. 2014 May;36(4):623-6. doi: 10.3109/0886022X.2014.882238. Epub 2014 Feb 6.

PMID:
24502587
13.

Combination treatment with plasmapheresis and rituximab for recurrent focal segmental glomerulosclerosis after renal transplantation.

Tsagalis G, Psimenou E, Nakopoulou L, Laggouranis A.

Artif Organs. 2011 Apr;35(4):420-5. doi: 10.1111/j.1525-1594.2010.01068.x.

PMID:
20637013
14.

Plasmapheresis for recurrent posttransplant focal segmental glomerulosclerosis.

Garcia CD, Bittencourt VB, Tumelero A, Antonello JS, Malheiros D, Garcia VD.

Transplant Proc. 2006 Jul-Aug;38(6):1904-5.

PMID:
16908318
15.

Recurrent focal glomerulosclerosis in pediatric renal allografts: the Miami experience.

Hubsch H, Montané B, Abitbol C, Chandar J, Shariatmadar S, Ciancio G, Burke G, Miller J, Strauss J, Zilleruelo G.

Pediatr Nephrol. 2005 Feb;20(2):210-6. Epub 2004 Dec 17.

PMID:
15605284
16.

Case report: successful treatment of recurrent focal segmental glomerulosclerosis with a novel rituximab regimen.

Stewart ZA, Shetty R, Nair R, Reed AI, Brophy PD.

Transplant Proc. 2011 Dec;43(10):3994-6. doi: 10.1016/j.transproceed.2011.10.051.

PMID:
22172885
17.

Prediction and treatment of recurrent focal segmental glomerulosclerosis after renal transplantation in children.

Dall'Amico R, Ghiggeri G, Carraro M, Artero M, Ghio L, Zamorani E, Zennaro C, Basile G, Montini G, Rivabella L, Cardillo M, Scalamogna M, Ginevri F.

Am J Kidney Dis. 1999 Dec;34(6):1048-55.

PMID:
10585314
18.

Focal segmental glomerular sclerosis in renal transplant recipients: predicting early disease recurrence may prolong allograft function.

Sener A, Bella AJ, Nguan C, Luke PP, House AA.

Clin Transplant. 2009 Jan-Feb;23(1):96-100. doi: 10.1111/j.1399-0012.2008.00908.x.

PMID:
19200221
19.

Pretransplantation combined therapy with plasmapheresis and rituximab in a second living-related kidney transplant pediatric recipient with a very high risk for focal segmental glomerulosclerosis recurrence.

Chikamoto H, Hattori M, Kuroda N, Kajiho Y, Matsumura H, Fujii H, Ishizuka K, Hisano M, Akioka Y, Nozu K, Kaito H, Shimizu M.

Pediatr Transplant. 2012 Nov;16(7):E286-90. doi: 10.1111/j.1399-3046.2011.01610.x. Epub 2011 Nov 30.

PMID:
22129369
20.

Fatal late-onset Pneumocystis pneumonia after rituximab: administration for posttransplantation recurrence of focal segmental glomerulosclerosis--case report.

Dęborska-Materkowska D, Kozińska-Przybył O, Mikaszewska-Sokolewicz M, Durlik M.

Transplant Proc. 2014 Oct;46(8):2908-11. doi: 10.1016/j.transproceed.2014.09.010.

PMID:
25380948

Supplemental Content

Support Center